A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2002
11/06/2002	EP1097159B1 Phosphinous and phosphonic acid derivatives used as medicaments
11/06/2002	EP1091966B1 N-terminal site selective inhibitors of human angiotensin conversion enzyme (ace)
11/06/2002	EP1012137B1 Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
11/06/2002	EP0993459B1 Compounds useful for inhibition of farnesyl protein transferase
11/06/2002	EP0981327B1 Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors
11/06/2002	EP0966487B1 Polyvalent carbohydrate molecules
11/06/2002	EP0927168B1 1,3-diheterocyclic metalloprotease inhibitors
11/06/2002	EP0901373B1 Alpha v Beta 3 ANTAGONISTS
11/06/2002	EP0781280B1 Derivatives of benzopyran and of benzothiopyran, their preparation and their use as agonists of dopaminergic receptors
11/06/2002	EP0773959B1 Adrenergic receptor
11/06/2002	EP0623134B1 Metal complexes of water soluble texaphyrins
11/06/2002	CN1378591A Bacterial protection
11/06/2002	CN1378551A 嘌呤衍生物 Purine derivatives
11/06/2002	CN1378550A Partial or full A1 agonists-N6 heterocyclic 5' thio substituted adenosine devivatives
11/06/2002	CN1378544A Substituted azoles compounds
11/06/2002	CN1378542A FAB I inhibitors
11/06/2002	CN1378541A Inhibitors of c-JUN N-terminal kinase (JNK) and other protein kinases
11/06/2002	CN1378540A New piperazine and piperidine compounds
11/06/2002	CN1378537A 嘧啶衍生物 Pyrimidine derivatives
11/06/2002	CN1378536A Neutral-cationic lipid for nuelci acid and drug delivery
11/06/2002	CN1378535A 四氢喹啉衍生物 Tetrahydroquinoline derivative
11/06/2002	CN1378534A Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of coagulation cascade
11/06/2002	CN1378533A Phenoxypropylamine compounds
11/06/2002	CN1378532A Substituted 1,5-dihydropyrrol-2-on derivatives as NMDA receptor antagonists for treatment of pain
11/06/2002	CN1378528A Use of carbonylamino derivatives against CNS disorders
11/06/2002	CN1378455A Use of diterpenoid triepoxides as anti-proliferative agent
11/06/2002	CN1378450A Novel class of cytodifferentiating agents and histone deactylase inhibitors, and methods of use thereof
11/06/2002	CN1378449A Iron chelators and use thereof
11/06/2002	CN1377887A Polypeptide for inhibiting growth and migration of blood vessel endothelial cell and endothelial stem cell and its preparing method and use
11/06/2002	CN1377881A Intermediate for preparing cascade polymeric ligand and contrast medium
11/06/2002	CN1377880A Compound for curing vascular complication, its preparing method and treating use
11/06/2002	CN1377879A New alpha-amino acid sulfuryl compounds, its preparing method and medicinal composition containing them
11/06/2002	CN1377704A Anti-disease silk increasing agent for silk worm
11/06/2002	CN1377654A Biological wall breaking technology for rape melissa powder
11/06/2002	CN1377643A Health article containing tea polyphenol for resisting poor uranium bomb and preventing leukemia
11/06/2002	CN1377640A External preparatino for skin
11/06/2002	CN1093860C Pyridazino-[4,5-b]-quinoline 5-oxide derivatives, their preparation and their use as glycine antagonists
11/06/2002	CN1093859C Novel indole-2,3-dione-3-oxime derivatives
11/06/2002	CN1093856C Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclamide compounds
11/06/2002	CN1093852C 维生素ｄ酰胺衍生物 Amide derivatives of vitamin d
11/06/2002	CN1093767C Protein kinase C inhibitors
11/06/2002	CN1093766C Use of thexpahyrin in preparation of medicament for use with a chemotherapeutic agent in cancer chemosensitization
11/06/2002	CN1093764C Medical liquor for nourishing kindney
11/06/2002	CN1093761C New pharmacological use of all-receptor antagonists
11/06/2002	CN1093759C 蛋白激酶c抑制剂 Protein kinase c inhibitor
11/05/2002	US6476214 Inhibition of cytokine production
11/05/2002	US6476197 Polypeptides having interferon-γ inducing activity
11/05/2002	US6476193 NLK1 protein and NLK1 protein complexes
11/05/2002	US6476187 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
11/05/2002	US6476077 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists
11/05/2002	US6476062 Chemokine receptor antagonists
11/05/2002	US6476060 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity
11/05/2002	US6476052 Isoindolines, method of use, and pharmaceutical compositions
11/05/2002	US6476049 1-formyl-n-(2-(4-(5h-dibenzo(a,d)cyclohepten-5-ylidene)-1 -piperidinyl)) ethyl isonipecotic acid amide or analogs thereof
11/05/2002	US6476044 Use of morphine derivatives as medicaments for the treatment of neuropathic problems
11/05/2002	US6476041 1,4 substituted piperidinyl NMDA/NR2B antagonists
11/05/2002	US6476038 Amino substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines
11/05/2002	US6476031 Quinazoline derivatives as medicaments
11/05/2002	US6476029 7-alkyl- and cycloalkyl-substituted imidazotriazinones
11/05/2002	US6476028 Compounds and methods
11/05/2002	US6476026 Compounds and compositions as protease inhibitors
11/05/2002	US6476023 Aromatic heterocyclic compounds as anti-inflammatory agents
11/05/2002	US6476018 Fused imidazole derivatives as multidrug resistance modulators
11/05/2002	US6476016 Inhibiting loss of blood platelets, inhibiting formation of blood platelet aggregates, inhibiting formation of fibrin, inhibiting thrombus formation, and inhibiting embolus formation
11/05/2002	US6476010 Orally administering to a post-menopausal woman a fat soluble vitamin and a fat soluble vitamin absorption increasing effective amount of l-carnitine or salts
11/05/2002	US6475988 Methods to increase white blood cell survival after chemotherapy
11/05/2002	US6475986 Uses of THANK, a TNF homologue that activates apoptosis
11/05/2002	US6475983 Water-soluble polypeptides having a high affinity for α and β interferons
11/05/2002	US6475796 Vascular endothelial growth factor variants
11/05/2002	US6475766 Human osteoclast-derived cathepsin
11/05/2002	US6475753 94 Human Secreted Proteins
11/05/2002	US6475746 Method of obtaining a composition comprising a 5-HT1D selective compound
11/05/2002	US6475735 Human BMP-2 promoter and method for exploring bone-related substance by using the same
11/05/2002	US6475547 Immunoglobulin-rich milk, production and use thereof
11/05/2002	US6475518 Methods and compositions for treatment of disorders associated with chlamydia and similar bacterial infection
11/05/2002	US6475509 Covalent conjugates of sodium channel blockers and active compounds
11/05/2002	US6475494 In an oral dosage form, providing a combination product analgesically effective when administered orally, but which is aversive in addicts at the same dose or higher dose than prescribed; prevention of drug abuse, drug dependency
11/05/2002	US6475490 Compositions and methods for promoting tissue repair using heat shock proteins
11/05/2002	US6475487 Treatment of a patient by administering an antibody that inhibits cathepsin O
11/05/2002	US6475467 Medicinal aerosol formulations
11/05/2002	CA2324467C Formulations for protection of peg-interferon alpha conjugates
11/05/2002	CA2284717C Pet food composition
11/05/2002	CA2109322C Bombesin analogs
11/05/2002	CA2038379C Trifluoromethyl mercaptan and mercaptoacyl derivatives and method of using same
11/05/2002	CA2038029C 1-alkyl-, 1-alkenyl- and 1-alkynylaryl-2-amino-1,3-propanediols and related compounds, a process and intermediates for their preparation and theeir use as medicaments
11/05/2002	CA2011833C Novel polypeptide and production thereof
11/02/2002	CA2384344A1 4-(2-pyridyl)piperizines having 5ht7 receptor agonist activity
10/2002
10/31/2002	WO2002086443A2 Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
10/31/2002	WO2002086123A2 A human g-protein coupled receptor, hgprbmy11, expressed highly in heart and variants thereof
10/31/2002	WO2002086105A1 Delivery of polynucleotide agents to the central nervous sysstem
10/31/2002	WO2002086087A2 Cytokine protein family
10/31/2002	WO2002086085A2 Human timp-1 antibodies
10/31/2002	WO2002086078A2 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
10/31/2002	WO2002086069A2 Secreted proteins
10/31/2002	WO2002085941A2 Modified interferon alpha with reduced immunogenicity
10/31/2002	WO2002085940A2 New polynucleotides and polypeptides of the erythropoietin gene
10/31/2002	WO2002085928A2 Modified cyclosporine which can be used as a pro-drug and use thereof
10/31/2002	WO2002085906A2 Phthalazinones derivatives useful as pde4/7 inhibitors
10/31/2002	WO2002085905A1 Novel adenine derivatives
10/31/2002	WO2002085903A2 Amyloid plaque aggregation inhibitors and diagnostic imaging agents

1 ... 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 ... 1564